Roundtable: Lab of the Future
Adapting for Covid-19
Wednesday, April 8, 11:30 am-1:00 pm EDT online

Join us to learn about agile reconfiguring of the New York Blood Center's research labs to address Covid-19. During this truly profound moment, new models are emerging across the vital biomedical research, development, regulatory, and care landscapes.
Christopher D. Hillyer, MD
President and CEO of New York Blood Center (NYBC)

New York Blood Center has been instrumental in developing responses to MERS, SARS, EBOLA, HIV, West NIle Virus, and African Swine Fever. Through its nimble structures, NYBC is able to leverage diverse researchers and innovative approaches in real time.

Dr. Hillyer will speak on developing vaccines, therapies, and surveillance.

He serves as Professor, Department of Medicine, Weill Cornell Medical College, New York, New York. He was previously the tenured, endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine. He is a co-founder of the Transfusion & Transplantation Technologies, Inc. (3Ti), and HemeXcel, and holds a number of patents related to transfusion medicine and cellular therapies.
Reza Agahian
Principal, Research & Academic Architecture

Reza will speak on adapting laboratories for Covid-19 and other efforts requiring Enhanced BSL-3 labs.

He is an architect with over 30 years of experience in the planning, design, and construction administration of major commercial, scientific research, and teaching facilities.

His specialized expertise is in the detailed functional design of high-tech scientific buildings and their associated components, including diagnostic and analytical requirements, process infrastructure, and laboratory support systems.

Reza’s experience includes clean rooms, vivarium, biohazard suites, and molecular laboratories. He is a specialist in managing the planning through construction phasing and sequencing of technologically sophisticated facilities.
Westchester Biotech Project Co-Founders:
Michael Welling , Chief Strategy Officer; Partner, Meridian Risk Management
Joanne Gere , Executive Director
For more, please visit  www.westchesterbiotechproject.org .